The Discounted Cash Flow (DCF) valuation of Teva Pharmaceutical Industries Ltd (TEVA.TA) is 424.25 USD. With the latest stock price at 6,048.00 USD, the upside of Teva Pharmaceutical Industries Ltd based on DCF is -93.0%.
Based on the latest price of 6,048.00 USD and our DCF valuation, Teva Pharmaceutical Industries Ltd (TEVA.TA) is a sell. selling TEVA.TA stocks now will result in a potential gain of 93.0%.
| Range | Selected | |
| WACC / Discount Rate | 7.7% - 9.8% | 8.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (94.40) - 1,739.31 | 424.25 |
| Upside | -101.6% - -71.2% | -93.0% |